From Development to Patient Impact: Biohaven’s Nurtec™ Success Story
To learn more about Biohaven's success story, read our case study. Read the case study
CertaraSeptember 13, 2024
Certara’s MIDD Oncology Capabilities
Improve Oncology Study Decisions with Certara's MIDD Team Transcript: The pace of oncology drug…
CertaraAugust 7, 2024
Certara Talks: PAGE 2024
Learn more about our Modeling & Simulation Services Transcript: Hello, and welcome to Certara…
CertaraAugust 5, 2024
Certara Talks: ASCPT 2024
Learn more about how our pharmacometricians can help you de-risk your drug development program. Learn…
CertaraMay 31, 2024
Secondary Intelligence™ Demo
Discover how Secondary Intelligence™ can support your compound assessments by predicting off-target activities and potential…
CertaraMay 24, 2024
Explore the World of Endogenous Biomarkers with Simcyp™!
Endogenous biomarkers play a pivotal role in comprehending drug-body interactions, shaping drug development, and propelling…
CertaraApril 26, 2024
